Revolution Medicines Announces Publication of Scientific Paper Describing Novel Class of Anti-Tumor Compounds Targeting mTORC1
Findings Published in Nature Chemical Biology Support Clinical Development of RMC-5552, the Company’s First-in-Class, Phase…
Indonesia’s KAI Launches Farmer-Trader Train, Expands Facial Recognition Tech Ahead of 2025/2026 Holiday Travel Surge
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Criminal IP Reveals Global React2Shell RCE Exposure Across React Server Components
Dental Digital Launches Marketing Services for Dental Practices